Over 35,000 Americans provided comments on the Drug Enforcement Administration’s (DEA) proposed rule, “Telemedicine Prescribing of Controlled Substances When the Practitioner and the Patient Have Not Had a Prior In-Person Medical Evaluation.”
In comment letters responding to the DEA’s proposed rule, hundreds of key stakeholders highlighted the need for a special registration for telemedicine and the dangerous impact on patient access the proposed rule has on millions of patients.
Read a snapshot of the comments below or here.
Loading...
Reload document 
Open in new tab